ArticleJournal of lipid research2026
The bile acid-CoA ligase, FATP5, is necessary for the synthesis of N-acyl taurines in the liver.
Article in Journal of lipid research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
N-acyl taurines (NAT) are endogenous, bioactive conjugates of fatty acids and taurine with roles in carbohydrate and lipid metabolism. In the liver, NATs are synthesized by bile acid-CoA:amino acid N-acyltransferase (BAAT), which also conjugates bile acids to taurine or glycine, suggesting an overlapping hepatic synthesis pathway. BAAT catalyzes the transfer of an acyl-chain from an activated coenzyme A (CoA) to taurine, but the hepatic enzyme responsible for synthesizing the acyl-CoA remains unknown. Using liver transcriptomics in mice unable to hydrolyze NATs, we identified Slc27a5, which encodes the acyl-CoA synthetase, fatty acid transport protein 5 (FATP5), as a potential regulator of hepatic NAT synthesis. In vivo knockdown of the enzyme confirmed that FATP5 is necessary for hepatic NAT synthesis and upstream of BAAT, likely through its acyl-CoA synthetase activity. The dual function of this enzyme in activating both fatty acids and bile acids for conjugation identifies a functional overlap between the hepatic NAT and bile acid production pathway.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.